EcoDrugPlus

Ensembl ID : ENSMSIG00000006956
Gene Symbol: AHR
2 Cross references
169 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSMSIG00000028839
Gene Symbol: DHCR24
1 Cross references
223 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase

Ensembl ID : ENSMSIG00000002008
Gene Symbol: HMGCR
1 Cross references
285 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSMSIG00000004298
Gene Symbol: PDPK1
1 Cross references
255 Possible Orthologues:

4-Hydroxyphenylpyruvic Acid Dioxygenase

Ensembl ID : ENSMSIG00000014704
Gene Symbol: HPD
1 Cross references
219 Possible Orthologues:

5 Hydroxytryptamine (Serotonin) Receptor 4

Ensembl ID : ENSMSIG00000005233
Gene Symbol: HTR4
1 Cross references
215 Possible Orthologues:

5' Nucleotidase, Ecto

Ensembl ID : ENSMSIG00000026329
Gene Symbol: NT5E
1 Cross references
262 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1b

Ensembl ID : ENSMSIG00000017311
Gene Symbol: HTR1B
1 Cross references
260 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1f

Ensembl ID : ENSMSIG00000021469
Gene Symbol: HTR1F
1 Cross references
160 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2a

Ensembl ID : ENSMSIG00000020690
Gene Symbol: HTR2A
1 Cross references
233 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b

Ensembl ID : ENSMSIG00000003004
Gene Symbol: HTR2B
1 Cross references
219 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 3a

Ensembl ID : ENSMSIG00000012846
Gene Symbol: HTR3A
1 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).